Relay Therapeutics, Inc. - COM (RLAY)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
158M
Holdings value Q3 2024
$1.11B
Value change Q3 2024
+$213M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
192
Number of buys Q3 2024
113
Number of sells Q3 2024
-70
Average buys Q3 2024 %
+0.003%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 158M $1.11B +$213M $7.08 192
2024 Q2 127M $826M -$19M $6.52 169
2024 Q1 129M $1.07B -$13.2M $8.30 179
2023 Q4 127M $1.4B -$521K $11.01 175
2023 Q3 129M $1.08B -$22.3M $8.41 167
2023 Q2 129M $1.62B -$19.9M $12.56 159
2023 Q1 131M $2.16B +$52.8M $16.47 154
2022 Q4 128M $1.91B +$58.7M $14.94 160
2022 Q3 123M $2.76B +$23.5M $22.37 150
2022 Q2 121M $2.02B +$125M $16.75 136
2022 Q1 113M $3.38B +$67.6M $29.93 132
2021 Q4 111M $3.41B +$589M $30.71 127
2021 Q3 91.8M $2.89B +$74.3M $31.53 135
2021 Q2 89.1M $3.26B +$138M $36.59 123
2021 Q1 85.5M $2.95B -$171M $34.57 134
2020 Q4 87.7M $3.64B +$107M $41.56 114
2020 Q3 84.7M $3.6B +$3.6B $42.59 94